Ravi, P., Kwak, L., Xie, W., D'Amico, A. V., Dignam, J., Fizazi, K., James, N. D., Teuff, G. L., Nguyen, P., Sandler, H. M., Sartor, A. O., Sydes, M. R., Sweeney, C. (2025). Docetaxel with androgen deprivation therapy (ADT) and radiotherapy (RT) for high-risk localized prostate cancer (HRLPC): An ICECaP individual patient-data (IPD) meta-analysis of randomized controlled trials (RCTs).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5013